Literature DB >> 20308642

Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program.

Vincent Jarlier1, David Trystram, Christian Brun-Buisson, Sandra Fournier, Anne Carbonne, Laurence Marty, Antoine Andremont, Guillaume Arlet, Annie Buu-Hoi, Jean Carlet, Dominique Decré, Serge Gottot, Laurent Gutmann, Marie-Laure Joly-Guillou, Patrick Legrand, Marie-Hélène Nicolas-Chanoine, Claude-James Soussy, Michel Wolf, Jean-Christophe Lucet, Michelle Aggoune, Gilles Brücker, Bernard Régnier.   

Abstract

BACKGROUND: The Assistance Publique-Hôpitaux de Paris (AP-HP) institution administers 38 teaching hospitals (23 acute care and 15 rehabilitation and long-term care hospitals; total, 23 000 beds) scattered across Paris and surrounding suburbs in France. In the late 1980s, the proportion of methicillin resistance among clinical strains of Staphylococcus aureus (MRSA) reached approximately 40% at AP-HP.
METHODS: A program aimed at curbing the MRSA burden was launched in 1993, based on passive and active surveillance, barrier precautions, training, and feedback. This program, supported by the strong commitment of the institution, was reinforced in 2001 by a campaign promoting the use of alcohol-based hand-rub solutions. An observational study on MRSA rate was prospectively carried out from 1993 onwards.
RESULTS: There was a significant progressive decrease in MRSA burden (-35%) from 1993 to 2007, whether recorded as the proportion (expressed as percentage) of MRSA among S aureus strains (41.0% down to 26.6% overall; 45.3% to 24.2% in blood cultures) or incidence of MRSA cases (0.86 down to 0.56 per 1000 hospital days). The MRSA burden decreased more markedly in intensive care units (-59%) than in surgical (-44%) and medical (-32%) wards. The use of ABHR solutions (in liters per 1000 hospital days) increased steadily from 2 L to 21 L (to 26 L in acute care hospitals and to 10 L in rehabilitation and long-term care hospitals) following the campaign.
CONCLUSION: A sustained reduction of MRSA burden can be obtained at the scale of a large hospital institution with high endemic MRSA rates, providing that an intensive program is maintained for a long period.

Entities:  

Mesh:

Year:  2010        PMID: 20308642     DOI: 10.1001/archinternmed.2010.32

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  38 in total

Review 1.  Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?

Authors:  Steven Y C Tong; Luke F Chen; Vance G Fowler
Journal:  Semin Immunopathol       Date:  2011-12-11       Impact factor: 9.623

2.  Methicillin-resistant Staphylococcus-aureus-associated glomerulonephritis on the decline: decreased incidence since the 1990s.

Authors:  Joichi Usui; Masaki Kobayashi; Itaru Ebihara; Akio Koyama; Kunihiro Yamagata
Journal:  Clin Exp Nephrol       Date:  2010-11-13       Impact factor: 2.801

3.  Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events.

Authors:  J R Zahar; M Garrouste-Orgeas; A Vesin; C Schwebel; A Bonadona; F Philippart; C Ara-Somohano; B Misset; J F Timsit
Journal:  Intensive Care Med       Date:  2013-08-31       Impact factor: 17.440

4.  Antibiotic reduction campaigns do not necessarily decrease bacterial resistance: the example of methicillin-resistant Staphylococcus aureus.

Authors:  Lidia Kardas-Sloma; Pierre-Yves Boëlle; Lulla Opatowski; Didier Guillemot; Laura Temime
Journal:  Antimicrob Agents Chemother       Date:  2013-07-01       Impact factor: 5.191

5.  A survey of methicillin-resistant Staphylococcus aureus control strategies in Italy.

Authors:  A Pan; E Bombana; G Tura; C Curti; S Lorenzotti; P Mondello; A Patroni; E Tacconelli; V Rigobello; L Signorini; M Vizio; A Goglio
Journal:  Infection       Date:  2013-04-01       Impact factor: 3.553

6.  In 2035, will all bacteria be multidrug-resistant? No.

Authors:  François Barbier; Jeffrey Lipman; Marc J M Bonten
Journal:  Intensive Care Med       Date:  2016-04-18       Impact factor: 17.440

Review 7.  Epidemiology of antimicrobial resistance in bloodstream infections.

Authors:  Murat Akova
Journal:  Virulence       Date:  2016-04-02       Impact factor: 5.882

8.  Think (Gram) negative!

Authors:  Benedikt Huttner; Stephan Harbarth
Journal:  Crit Care       Date:  2010-06-25       Impact factor: 9.097

9.  Mupirocin/chlorexidine to prevent methicillin-resistant Staphylococcus aureus infections: post hoc analysis of a placebo-controlled, randomized trial using mupirocin/chlorhexidine and polymyxin/tobramycin for the prevention of acquired infections in intubated patients.

Authors:  C Camus; V Sebille; A Legras; B Garo; A Renault; P Le Corre; P-Y Donnio; A Gacouin; D Perrotin; Y Le Tulzo; E Bellissant
Journal:  Infection       Date:  2014-01-25       Impact factor: 3.553

10.  The reduction of nosocomial MRSA infection in Germany: an analysis of data from the Hospital Infection Surveillance System (KISS) between 2007 and 2012.

Authors:  Elisabeth Meyer; Christin Schröder; Petra Gastmeier; Christine Geffers
Journal:  Dtsch Arztebl Int       Date:  2014-05-09       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.